How to Analyze Continuous and Discrete Repeated Measures in Small-Sample Cross-Over Trials?
Biometrics · 2023
DOI: 10.1111/biom.13920 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, 2023. Verfasst von Johan Verbeeck und 9 weiteren Autor:innen. Beteiligte Einrichtung: Data Science Institute (DSI), Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), Hasselt University, Hasselt, Be…. Hauptthemen laut MEDLINE: Models, Statistical, Rare Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: WISS 2025 project 'IDA-Lab Salzburg', European Joint Programme on Rare Diseases (EJP RD), EU Horizon 2020.
Abstract (Originalsprache)
To optimize the use of data from a small number of subjects in rare disease trials, an at first sight advantageous design is the repeated measures cross-over design. However, it is unclear how these within-treatment period and within-subject clustered data are best analyzed in small-sample trials. In a real-data simulation study based upon a recent epidermolysis bullosa simplex trial using this design, we compare non-parametric marginal models, generalized pairwise comparison models, GEE-type models and parametric model averaging for both repeated binary and count data. The recommendation of which methodology to use in rare disease trials with a repeated measures cross-over design depends on the type of outcome and the number of time points the treatment has an effect on. The non-parametric marginal model testing the treatment–time-interaction effect is suitable for detecting between group differences in the shapes of the longitudinal profiles. For binary outcomes with the treatment effect on a single time point, the parametric model averaging method is recommended, while in the other cases the unmatched generalized pairwise comparison methodology is recommended. Both provide an easily interpretable effect size measure, and do not require exclusion of periods or subjects due to incompleteness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Data Science Institute (DSI), Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), Hasselt University, Hasselt, Belgium.
- Team Biostatistics and Big Medical Data, Intelligent Data Analytics (IDA) Lab Salzburg, Paracelsus Medical University, Salzburg, Austria.
- Research and Innovation Management, Paracelsus Medical University Salzburg, Salzburg, Austria.
- Department of Pharmacy, Uppsala University, Uppsala, Sweden.
- Intelligent Data Analytics (IDA) Lab Salzburg, Department of Artificial Intelligence and Human Interfaces, University of Salzburg, Salzburg, Austria.
- Department of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria.
ORCID-Profile: Johan Verbeeck, Andrew Craig Hooker
Förderung
- WISS 2025 project 'IDA-Lab Salzburg'
- European Joint Programme on Rare Diseases (EJP RD), EU Horizon 2020
Zitieren
APA
Verbeeck, J., Geroldinger, M., Thiel, K., Hooker, A. C., Ueckert, S., Karlsson, M., Bathke, A. C., Bauer, J. W., Molenberghs, G., & Zimmermann, G. (2023). How to Analyze Continuous and Discrete Repeated Measures in Small-Sample Cross-Over Trials?. Biometrics. https://doi.org/10.1111/biom.13920
Vancouver
Verbeeck J, Geroldinger M, Thiel K, Hooker AC, Ueckert S, Karlsson M, et al. How to Analyze Continuous and Discrete Repeated Measures in Small-Sample Cross-Over Trials?. Biometrics. 2023. doi:10.1111/biom.13920
BibTeX
@article{Verbeeck2023,
author = {Verbeeck, Johan and Geroldinger, Martin and Thiel, Konstantin and Hooker, Andrew Craig and Ueckert, Sebastian and Karlsson, Mats and Bathke, Arne Cornelius and Bauer, Johann Wolfgang and Molenberghs, Geert and Zimmermann, Georg},
title = {How to Analyze Continuous and Discrete Repeated Measures in Small-Sample Cross-Over Trials?},
journal = {Biometrics},
year = {2023},
doi = {10.1111/biom.13920}
}
EUVIMED